The Motley Fool

MESOBLAST FPO (ASX: MSB) Share Price and News

 Chart and Price Data

20mins delayed

Bid/Ask /
Avg Daily Volume
Day Movement
Day High/Low /
52 Week Range -
Year Return (Capital)
As at
Please Wait...


share price higher

Why the Polynovo share price is now up 24x in 5 years

The Polynovo Ltd (ASX: PNV) share price is up 7% to $2.43 this lunchtime despite the biotech not releasing any specific news to the... More »

share price down

Why Mesoblast, NAB, Nearmap, & Santos shares crashed lower today

The National Australia Bank Ltd (ASX:NAB) share price and the Nearmap Ltd (ASX:NEA) share price are two of four crashing lower today... More »

Red arrow downward chart

Why the Mesoblast share price crashed 10% lower today

The Mesoblast limited (ASX:MSB) share price has crashed lower today after completing its $75 million institutional placement... More »

Mesoblast shares halted as it asks investors to tip in another $75 million

Mesoblast limited (ASX: MSB) needs more capital from investors. More »

bull vs bear

Paradigm reports “ground-breaking” osteoarthritis discovery: Is it the real deal?

Paradigm Biopharmaceuticals (ASX:PAR) is looking to partner with big pharma. More »

Winners Cup Trophy

Is Paradigm Biopharmaceuticals the share market’s next huge winner?

Paradigm: Buy the rumour, sell the news? More »

racing higher

Why Blackmores, Class, Mesoblast, & St Barbara shares raced higher today

The Blackmores Limited (ASX:BKL) share price and the Mesoblast limited (ASX:MSB) share price are two of four racing higher on Thursday... More »

business share price

Why Mesoblast, New Hope, Pilbara Minerals, & Syrah shares charged higher today

The Mesoblast limited (ASX:MSB) share price and the Syrah Resources Ltd (ASX:SYR) share price are two of four charging notably higher today... More »

Paradigm share price tanks despite positive clinical trial update

Paradigm Biopharmaceuticals Ltd (ASX: PAR) is a speccy biotech that could sink or soar. More »

Rocket soaring through the sky

Why the Mesoblast share price is going nuts today

Mesoblast limited (ASX: MSB) has signed an important partnership with Grünenthal. More »

share price higher

Why iSignthis, Leigh Creek, Mesoblast, & Santos shares charged higher

The iSignthis Ltd (ASX:ISX) share price and the Mesoblast limited (ASX:MSB) share price are two of four charging higher on Tuesday... More »

Mesoblast share price rockets 17% higher on Grünenthal partnership news

The Mesoblast Limited (ASX:MSB) share price has rocketed higher on Tuesday following the release of a positive update relating to its MPC-06-ID product... More »

bull and bear figurines facing off over stockmarket graph

Opthea share price lifts on clinical trial update: Is it a spec buy?

Opthea Ltd (ASX: OPT) is developing clinical treatments for eye diseases. More »

healthcare shares

Mesoblast share price edges higher on quarterly update

The Mesoblast Ltd (ASX: MSB) share price closed 0.6% higher on the ASX yesterday after the company reported its June 2019 quarterly update. More »